Antibody Libraries
Bring antibody discovery in-house with an exclusive antibody platform built specifically for your organization
Specifica builds and transfers custom Generation 3 antibody libraries to support internal research and development at your lab, facilitating antibody discovery that meets your needs at your pace. Each library combines highly developable therapeutic scaffolds, validated replicated natural diversity, and a unique client-exclusive HCDR3 repertoire to create a discovery platform optimized for affinity, diversity, developability and speed. Unlike shared libraries, each platform is built exclusively for a single customer, helping minimize the risk of overlapping discoveries with competitors. Our libraries don't just screen for antibodies that bind well; they are designed to produce antibodies with drug-like characteristics, reducing the amount of downstream engineering.
Available formats include VHH, scFv and Fab. Our scFv and Fab libraries are also available with a constant light chain. Within a format, we typically provide 4 sub-libraries, based on different therapeutic scaffolds, but can adapt to each client's needs.
Specifica libraries are ideal for organizations that want to:
- Build internal antibody discovery capabilities
- Reduce dependence on outsourcing
- Protect proprietary discovery strategies
- Accelerate biologics pipelines
Specifica Antibody Libraries Deliver:
Proven results
-
-
-
Nine of the top 20 pharma companies own a Specifica antibody library. With 30 custom libraries and counting, Specifica facilitates discovery at traditional pharma companies, emerging biopharma, academic research centers and AI companies.
-
-
True platform ownership
-
-
-
Conduct antibody discovery internally using your team and with full control of your programs
-
-
No royalties or milestone fees
-
-
-
Straightforward business terms without ongoing payments supports long-term innovation in your lab
-
-
Exclusivity
-
-
-
Each library is constructed using a unique, client-specific HCDR3 donor pool used only for that specific library.
-
-
~1026 possible combinations
>1010 transformants
Our approach delivers a one-of-a-kind library and virtually eliminates the risk of pursuing an antibody already identified by a competitor. The importance of this became clear when Genentech and Human Genome Sciences independently discovered identical antibodies against the same target from the same phage display library, leading to a patent dispute. The rise of next-generation sequencing has only heightened this risk.
Exclusive library
Built using a unique HDCR3 donor for maximum diversity — billions of antibodies for the most challenging targets — with built-in developability. You receive 4 sub-libraries representing different V families.
Technology transfer
• Library assets
• NGS data
• Vectors
• Protocols
• Training
• Discovery workflows
Affinity maturation module
Your library platform includes our affinity maturation module, delivering up to 1000-fold affinity improvement—while often improving developability—with a carefully designed and proven approach.
Scientific support
Your team will receive full training at Specifica's lab in Santa Fe, New Mexico, from the scientists who built the platform.
Royalty-free terms
Specifica doesn’t charge royalties, milestone-based fees or “research” fees for our work. We value transparency and clarity in our scientific and business and practices. You’ll know costs upfront before we start, and we won’t ask you to share your intellectual property or pay us licensing fees in perpetuity. Your molecules are yours; we won’t ask you to report back to us or allow us to conduct any audits.
Developability demonstrated
See how antibodies from a Gen3 scFv library performed in an external evaluation by a leading pharmaceutical company, with 81% meeting overall developability criteria.
Get In Touch
Contact Us
Contact Us
If you would like to get in touch with us please use the contact form or email address below.